期刊文献+

慢性鼻-鼻窦炎患者药物治疗的生存质量及相关研究 被引量:13

Investigation of quality of life on chronic rhinosinusitis following medication
原文传递
导出
摘要 目的使用鼻窦炎症状视觉模拟量表(VAS)及鼻窦炎专用量表-鼻腔鼻窦结局测试20(SNOT-20)中文版评价慢性鼻-鼻窦炎患者药物治疗前与治疗后不同时间的生存质量(QOL),探讨药物治疗对患者QOL的影响。方法收集慢性鼻-鼻窦炎患者100例作为实验组,给予药物联合治疗12周,每4周进行一次VAS评分及SNOT-20评分。另收集100例健康体检者作为对照组,进行一次相同的评分。分析实验组治疗前后及停药后患者VAS评分、SNOT-20评分的变化及与对照组的差异。结果实验组治疗前后及停药后VAS评分差异具有统计学意义(F=38.39,P<0.01)。实验组治疗12周后与对照组VAS评分比较差异具有统计学意义(t=7.93,P<0.01)。实验组VAS、CT评分于治疗后5个症状占比分别有所下降,每种症状的VAS、CT评分也有所下降。实验组治疗前后及停药后SNOT-20评分经单因素方差分析显示差异具有统计学意义(F=27.93,P<0.01)。实验组治疗12周后与对照组SNOT-20评分比较差异具有统计学意义(t=19.93,P<0.01)。实验组于治疗后各症状占比人数分别有所下降,每种症状的SNOT-20评分也有所下降。结论药物治疗作为慢性鼻-鼻窦炎的首选治疗方式,可有效改善患者的QOL,但长期小剂量使用的远期疗效尚有待进一步证实。 Objective To evaluate chronic rhino-sinusitis medication before treatment and quality of life (QOL) at dif- ferent times after treatment and to investigate the drug therapy on QOL of patients. Methods Using sinusitis symptom visual analog scale (VAS) and sinusitis special scale-sinonasal outcome Test 20 (SNOT-20), we collect 100 patients with chronic rhinitis-sinusitis as the experimental group receiving 12 weeks combination therapy drugs, once every four weeks, and another 100 healthy volunteers as the control group. Results By univariate analysis, the VAS score showed a significant difference (F = 38. 39, P 〈 0.01 ) before and after treatment in the experimental group, and it showed a significant difference ( t --7.93, P 〈0.01 ) between the 12-week after treatment group and the control group; After the drug treatment, VAS and CT score of 5 symptoms accounted decreases and each symptom rate also declined. By univariate analysis, the SNOT-20 score also showed a significant difference (F = 27.93, P 〈 0.01 ) before and after treatment in the experimental group, and it showed a significant difference (t = 19.93, P 〈 0.01 ) between the 12-week after treatment group and the control group ; After the drug treatment, patents with each symptom accounted decrease and each symptom rate also declined. Conclusion Drug treatment can effectively improve the QOL chronic rhinitis sinusitis, whether needing long-term low-dose use remains further confirmation.
出处 《山东大学耳鼻喉眼学报》 CAS 2016年第1期26-30,共5页 Journal of Otolaryngology and Ophthalmology of Shandong University
基金 深圳市科技计划项目(201203322) 深圳市龙岗区科技局资助项目(YS2012085)
关键词 慢性鼻-鼻窦炎 药物治疗 生存质量 Chronic rhinitis-sinusitis Medication Quality of life
  • 相关文献

参考文献14

  • 1袁海,韩爱国,白晓明,张永奇.慢性鼻-鼻窦炎鼻息肉药物治疗进展概述[J].临床耳鼻咽喉头颈外科杂志,2011,25(8):382-384. 被引量:28
  • 2Hissaria P, Smith W, Wormald P J, et al. Short course of systemic corticosteroids in sinonasal polyposis : a doub- le-blind, randomized, placebo-controlled trial with evalu- ation of outcome measures [J]. J Allergy Clin Immunol, 2006, 118(1) :128-133.
  • 3Fokkens W J, Lurid V J, Mullol J, et al. European posi- tion paper on rhinosinusitis and nasal polyps 2012 [ J ]. Rhinol Suppl, 2012, 5 (23) : 1-298.
  • 4慢性鼻-鼻窦炎诊断和治疗指南(2008年,南昌)[J].中华耳鼻咽喉头颈外科杂志,2009,44(1):6-7. 被引量:571
  • 5左可军,方积乾,Piccirillo JF,王慧,许庚.鼻腔鼻窦结局测试-20(SNOT-20)量表中文版的研制[J].中华耳鼻咽喉头颈外科杂志,2008,43(10):751-756. 被引量:175
  • 6Melen I. Chronic sinusitis: clinical and pathophysiological aspects[J]. Acta Otolaryngol Suppl, 1994, 515 ( 1 ) :45- 48.
  • 7Blackwell D C J, Coles R. Summary health statistics for US adults: National Health Interview Survey 1997. Na- tional Center for Health Statistics [J]. Vital Health Stat, 2002, 205 : 1-109.
  • 8Zhang L, Han D, Huang D, et al. Prevalence of self-re ported allergic rhinitis in eleven major cities in china[ J ]. Int Arch Allergy Immunol, 2009, 149( 1 ) :47-57.
  • 9Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007 [J]. Rhinol Suppl, 2007(20) : 1-136.
  • 10Wallwork B, Coman W, Mackay-Sim A, et al. A doub- le-blind,randomized, placebo-controlled trial of macroli de in the treatment of chronic rhinosinusitis [J]. Laryngo- scope, 2006, 116(2) :189-193.

二级参考文献53

共引文献778

同被引文献115

引证文献13

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部